SEROLOGICAL BIOMARKERS OF TYPE III AND IV COLLAGEN REMODELING PREDICT AND MONITOR INFLIXIMAB TREATMENT RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Marta Sorokina Alexdóttir  1     Arno R. Bourgonje  2     Morten Asser Karsdal  2     Anne-Christine Bay-Jensen  2     Klaas Nico Faber  2     Roberta Loveikyte  2     Hendrik M. van Dullemen  2     Marijn C. Visschedijk  2     Eleonora A. M. Festen  2     Rinse K. Weersma  2     Gerard Dijkstra  2     Joachim Mortensen  2    
1 Nordic Bioscience, Herlev, Denmark
2 University of Groningen, University Medical Center Groningen, Groningen, Netherlands

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing